Studies currently underway or underway shortly include assessments of transmissibility, severity of infection (including symptoms), performance of vaccines and diagnostic tests, and effectiveness of treatments.
WHO encourages countries to contribute the collection and sharing of hospitalized patient data through the WHO COVID-19 Clinical Data Platform to rapidly describe clinical characteristics and patient outcomes.
15915
将在数日或数周内提供更多信息。
More information will emerge in the coming days and weeks.
15916
世卫组织病毒进化技术咨询小组将继续监测和评估现有数据，并评估奥密克戎的突变如何改变此病毒的行为。
WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus.
15917
建议国家采取的行动
Recommended actions for countries
15918
在将奥密克戎定为需要关注的变异株之后，世卫组织建议各国采取行动，其中包括：加强病例监测和测序；
As Omicron has been designated a Variant of Concern, there are several actions WHO recommends countries to undertake, including enhancing surveillance and sequencing of cases; sharing genome sequences on publicly available databases, such as GISAID; reporting initial cases or clusters to WHO; performing field investigations and laboratory assessments to better understand if Omicron has different transmission or disease characteristics, or impacts effectiveness of vaccines, therapeutics, diagnostics or public health and social measures.
15919
通过公开可用的数据库（如全球共享所有流感数据行动 GISAID）共享基因组序列；
More detail in the announcement from 26 November.
15920
各国应在风险分析的基础上，遵循科学方针，继续实施有效的公共卫生措施，全面抑制COVID-19传播。
Countries should continue to implement the effective public health measures to reduce COVID-19 circulation overall, using a risk analysis and science-based approach .